We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$1.08T
AUM Growth
+$125B
Cap. Flow
+$32.6B
Cap. Flow %
3.01%
Top 10 Hldgs %
27.52%
Holding
4,738
New
85
Increased
3,720
Reduced
276
Closed
123

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.81B
2
MSFT icon
Microsoft
MSFT
+$1.34B
3
AAPL icon
Apple
AAPL
+$1.25B
4
AMZN icon
Amazon
AMZN
+$1.17B
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$480M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Financials 12.91%
3 Healthcare 12.22%
4 Consumer Discretionary 10.6%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGVN
4626
Longeveron
LGVN
$24.1M
-9,024
Closed -$123K
MLGO
4627
MicroAlgo
MLGO
$43.8M
-6
Closed -$31.4K
NVVE
4628
DELISTED
Nuvve Holding Corp
NVVE
0
-$16.5K
PCSA icon
4629
Processa Pharmaceuticals
PCSA
$6.28M
-244
Closed -$40.8K
PRSO icon
4630
Peraso
PRSO
$10.4M
-3,027
Closed -$33.9K
REBN icon
4631
Reborn Coffee
REBN
$11.7M
-2,665
Closed -$11.9K
REVB icon
4632
Revelation Biosciences
REVB
$4.49M
-6
Closed -$17.9K
RNAZ icon
4633
TransCode Therapeutics
RNAZ
$4.54M
-1
Closed -$8.61K
SGLY icon
4634
Singularity Future Technology
SGLY
$5.95M
-80
Closed -$6.08K
TENX icon
4635
Tenax Therapeutics
TENX
$498M
-1,851
Closed -$40.7K
TGL icon
4636
Treasure Global
TGL
$5.57M
-4
Closed -$24.8K
TTNP
4637
DELISTED
Titan Pharmaceuticals
TTNP
-4,397
Closed -$29K
UXIN
4638
Uxin Ltd
UXIN
$266M
-2,446
Closed -$17.1K
EMPD
4639
Empery Digital
EMPD
$81.5M
0
-$9.51K
WNS
4640
DELISTED
WNS Holdings
WNS
-61,308
Closed -$3.87M
LFWD icon
4641
ReWalk Robotics
LFWD
$20.2M
-353
Closed -$23.1K
SER icon
4642
Serina Therapeutics
SER
$32.8M
-4,009
Closed -$54.3K
SOLV icon
4643
Solventum
SOLV
$14.7B
$0 ﹤0.01%
+2,733,775
New +$205M
QCLS
4644
Q/C Technologies Inc
QCLS
$23.2M
-97
Closed -$75.4K
NBIS
4645
Nebius Group N.V.
NBIS
$53.4B
-280,281
Closed -$3.59M
BNT
4646
Brookfield Wealth Solutions
BNT
$12.3B
-22,115
Closed -$781K
FMTO
4647
DELISTED
Femto Technologies Inc. Common Stock
FMTO
0
-$5.9K
PIK
4648
DELISTED
Kidpik Corp. Common Stock
PIK
-4,003
Closed -$7.41K
VCNX
4649
DELISTED
Vaccinex, Inc. Common Stock
VCNX
-1,150
Closed -$10.7K
EVA
4650
DELISTED
Enviva Inc.
EVA
-656,615
Closed -$654K

Similar funds

Geode Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.

  • Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
  • Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
  • Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
  • Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
  • Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
  • Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
  • Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.